3. Zyprexa - Top 10 Warnings and Recalls

Drug: Zyprexa

2006 sales: $4.4 billion

Manufacturer: Eli Lilly

Safety concern: Warning; weight gain, metabolic problems

Related Articles:
> Lilly strengthens Zyprexa warnings. Report
> Study: 86% of docs cut Zyprexa use. Report
> Lilly to pay $500M to settle Zyprexa claims. Report
> Lilly ignored Zyprexa safety data on weight, blood sugar. Report
> Lilly accused of promoting off-label Zyprexa use. Report
> NYT accuses Lilly of hiding safety problems. Report

3. Zyprexa - Top 10 Warnings and Recalls
Read more on

Suggested Articles

Close-up of two people shaking hands with other people in the background
Pharma

Perrigo could use Upjohn-Mylan playbook for Amneal deal: analyst

Perrigo is treading water in its specialty drugs reinvention plan. Could a merger with another struggling drugmaker—à la Pfizer and Mylan—be the cure?

by Kyle Blankenship
novartis
Pharma

Ousted AveXis CSO denies wrongdoing in Novartis data scandal

AveXis' ex-CSO is "prepared to assert his rights and defend his conduct accordingly," a statement from a lawyer who recently represented Elon…

by Angus Liu
Insys Therapeutics Subsys
Manufacturing

Hikma picks up Insys naloxone spray in $12M bankruptcy buy

Hikma says it has picked up some pipeline products and nasal and sublingual spray equipment from Insys Therapeutics' bankruptcy.

by Eric Palmer